AAAAAA

   
Results: 1-9 |
Results: 9
PROPERTIES OF MUTANT SHV-5 BETA-LACTAMASES CONSTRUCTED BY SUBSTITUTION OF ISOLEUCINE OR VALINE FOR METHIONINE AT POSITION-69
Authors: GIAKKOUPI P MIRIAGOU V GAZOULI M TZELEPI E LEGAKIS NJ TZOUVELEKIS LS
Citation: P. Giakkoupi et al., PROPERTIES OF MUTANT SHV-5 BETA-LACTAMASES CONSTRUCTED BY SUBSTITUTION OF ISOLEUCINE OR VALINE FOR METHIONINE AT POSITION-69, Antimicrobial agents and chemotherapy, 42(5), 1998, pp. 1281-1283
INVASIVE METHODS AND CLINICAL FOLLOW-UP TO ESTIMATE HP ERADICATION SUCCESS
Authors: MICHOPOULOS S BALTA A MENTIS A SOTIROPOULOU M MIRIAGOU V PAPASPYROU I BOUZAKIS H TSIBOURIS P KRALIOS N
Citation: S. Michopoulos et al., INVASIVE METHODS AND CLINICAL FOLLOW-UP TO ESTIMATE HP ERADICATION SUCCESS, Gastroenterology, 114(4), 1998, pp. 931-931
EMERGENCE OF AN INHIBITOR-RESISTANT BETA-LACTAMASE (SHV-10) DERIVED FROM AN SHV-5 VARIANT
Authors: PRINARAKIS EE MIRIAGOU V TZELEPI E GAZOULI M TZOUVELEKIS LS
Citation: Ee. Prinarakis et al., EMERGENCE OF AN INHIBITOR-RESISTANT BETA-LACTAMASE (SHV-10) DERIVED FROM AN SHV-5 VARIANT, Antimicrobial agents and chemotherapy, 41(4), 1997, pp. 838-840
5-YEAR FOLLOW-UP OF CHILDREN TREATED FOR HELICOBACTER-PYLORI GASTRITIS
Authors: KATSIYIANNAKIS E GIANNAKIS M KARATAPANIS S GEORGOPOULOS S MIRIAGOU V PAGALIS A ARTIKIS V DANOS N MENTIS A KARIS C
Citation: E. Katsiyiannakis et al., 5-YEAR FOLLOW-UP OF CHILDREN TREATED FOR HELICOBACTER-PYLORI GASTRITIS, Gut, 41, 1997, pp. 165-165
TRANSFERABLE CEFOXITIN RESISTANCE IN ENTEROBACTERIA FROM GREEK HOSPITALS AND CHARACTERIZATION OF A PLASMID-MEDIATED GROUP-1 BETA-LACTAMASE (LAT-2)
Authors: GAZOULI M TZOUVELEKIS LS PRINARAKIS E MIRIAGOU V TZELEPI E
Citation: M. Gazouli et al., TRANSFERABLE CEFOXITIN RESISTANCE IN ENTEROBACTERIA FROM GREEK HOSPITALS AND CHARACTERIZATION OF A PLASMID-MEDIATED GROUP-1 BETA-LACTAMASE (LAT-2), Antimicrobial agents and chemotherapy, 40(7), 1996, pp. 1736-1740
IN-VITRO ACTIVITY OF CEFETAMET AGAINST ENTEROBACTERIA EXPRESSING AN SHV-5-TYPE BETA-LACTAMASE
Authors: TZOUVELEKIS LS PRINARAKIS EE GAZOULI M MIRIAGOU V TZELEPI E LEGAKIS NJ
Citation: Ls. Tzouvelekis et al., IN-VITRO ACTIVITY OF CEFETAMET AGAINST ENTEROBACTERIA EXPRESSING AN SHV-5-TYPE BETA-LACTAMASE, Chemotherapy, 42(5), 1996, pp. 324-328
CHARACTERIZATION OF THE US8.5 PROTEIN OF HERPES-SIMPLEX VIRUS
Authors: GEORGOPOULOU U KAKKANAS A MIRIAGOU V MICHAELIDOU A MAVROMARA P
Citation: U. Georgopoulou et al., CHARACTERIZATION OF THE US8.5 PROTEIN OF HERPES-SIMPLEX VIRUS, Archives of virology, 140(12), 1995, pp. 2227-2241
ESCHERICHIA-COLI EXPRESSED HERPES-SIMPLEX VIRUS GG1 AND GG2 PROTEINS IN ELISA AND IMMUNOBLOTTING ASSAYS
Authors: KAKKANAS A PAPADOGEORGAKI H MANSERVIGI R MIRIAGOU V GEORGOPOULOU U MAVROMARA P
Citation: A. Kakkanas et al., ESCHERICHIA-COLI EXPRESSED HERPES-SIMPLEX VIRUS GG1 AND GG2 PROTEINS IN ELISA AND IMMUNOBLOTTING ASSAYS, Intervirology, 38(6), 1995, pp. 346-351
EXPRESSION OF THE HERPES-SIMPLEX VIRUS TYPE-1 GLYCOPROTEIN-E IN HUMAN-CELLS AND IN ESCHERICHIA-COLI - PROTECTION STUDIES AGAINST LETHAL VIRAL-INFECTION IN MICE
Authors: MIRIAGOU V ARGNANI R KAKKANAS A GEORGOPOULOU U MANSERVIGI R MAVROMARA P
Citation: V. Miriagou et al., EXPRESSION OF THE HERPES-SIMPLEX VIRUS TYPE-1 GLYCOPROTEIN-E IN HUMAN-CELLS AND IN ESCHERICHIA-COLI - PROTECTION STUDIES AGAINST LETHAL VIRAL-INFECTION IN MICE, Journal of General Virology, 76, 1995, pp. 3137-3143
Risultati: 1-9 |